Can simethicone (dimethylpolysiloxane) be administered to a term newborn (≤28 days) with gas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Simethicone Be Given to Newborns?

Yes, simethicone can be administered to term newborns for gas symptoms, though the evidence shows it is no more effective than placebo for treating infantile colic.

Safety Profile

Simethicone is generally considered safe for use in newborns and infants. The FDA-approved drug label 1 indicates it is used for relief of pressure and bloating commonly referred to as gas, with no specific age restrictions listed. The medication has been studied in infants as young as 2 weeks of age 2.

Efficacy Considerations

The evidence regarding simethicone's effectiveness in newborns is disappointing:

  • A high-quality randomized, double-blind, placebo-controlled multicenter trial found simethicone was no more effective than placebo for infantile colic 2. In this study of 83 infants aged 2-8 weeks, 28% responded only to simethicone, 37% only to placebo, and 20% to both—with no statistically significant differences between groups.

  • A second double-blind crossover study confirmed these findings, showing no effect of simethicone on colic symptoms, though 67% of infants improved during treatment due to a high placebo effect 3.

  • A 2020 systematic review of reviews and guidelines concluded that simethicone had moderate to low evidence showing no benefit or negative effect for reducing crying time in colicky infants 4.

Important Caveats and Warnings

Potential Drug Interactions

Avoid concurrent use of simethicone with oral lactase treatment. A 2024 retrospective study found that simethicone reduced the efficacy of lactase treatment in infants with lactose intolerance 5. This is a critical consideration when evaluating gas symptoms that may be lactose-related.

Rare Adverse Event

One case report documented simethicone retinopathy in an immature infant, with retinal findings consistent with an embolic phenomenon possibly from systemic absorption 6. While extremely rare, this highlights that simethicone is not entirely without risk in vulnerable populations.

Clinical Algorithm

When a newborn presents with gas symptoms:

  1. Provide parental education and reassurance as first-line management (supported by national guidelines 4)
  2. Evaluate feeding technique and maternal diet if breastfeeding
  3. Consider probiotics if breastfed—strongest evidence for reducing crying time (25-65 minutes per 24 hours) 4
  4. Simethicone may be offered but counsel parents that it works no better than placebo
  5. Do NOT combine simethicone with lactase if lactose intolerance is suspected 5

Bottom Line

While simethicone can be safely administered to term newborns, its use should be considered primarily for parental reassurance rather than expected therapeutic benefit, given the robust evidence showing equivalence to placebo 2, 3, 4. Probiotics for breastfed infants have stronger evidence for symptom reduction 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.